{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T03:23:05Z","timestamp":1784258585701,"version":"3.55.0"},"reference-count":62,"publisher":"Informa UK Limited","issue":"12","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Drug Metabolism & Toxicology"],"published-print":{"date-parts":[[2018,12,2]]},"DOI":"10.1080\/17425255.2018.1550485","type":"journal-article","created":{"date-parts":[[2018,11,27]],"date-time":"2018-11-27T10:49:33Z","timestamp":1543315773000},"page":"1197-1207","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":16,"title":["Pharmacokinetic drug evaluation of letermovir prophylaxis for cytomegalovirus in hematopoietic stem cell transplantation"],"prefix":"10.1080","volume":"14","author":[{"given":"Barbara","family":"Deleenheer","sequence":"first","affiliation":[{"name":"Pharmacy Department, University Hospitals Leuven, Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Spriet","sequence":"additional","affiliation":[{"name":"Pharmacy Department, University Hospitals Leuven, Leuven, Belgium"},{"name":"KU Leuven, Department of Pharmaceutical and Pharmacological Sciences, Clinical Pharmacology and Pharmacotherapy, Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Maertens","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, KU Leuven, Leuven, Belgium"},{"name":"Clinical Department of Haematology, University Hospitals Leuven, Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2018,12,4]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu364"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-11-679639"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2013.09.004"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1016\/j.idc.2010.01.008"},{"issue":"4","key":"CIT0005","first-page":"209","volume":"10","author":"Ljungman P","year":"1995","journal-title":"Semin Respir Infect"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(15)00289-6"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e3181cee42f"},{"key":"CIT0008","unstructured":"Clinical pharmacology and biopharmaceutics review(s) PREVYMIS [Internet]. Silver Spring (USA): FDA; [updated 2017, Cited 2018 Nov 09]. 2017. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2017\/209939Orig1s000,209940Orig1s000ClinPharmR.pdf"},{"key":"CIT0009","unstructured":"Clinical review PREVYMIS [Internet]. Silver Spring (USA): FDA; [updated 2017, cited 09\/ 11\/2018].Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2017\/209939Orig1s000,209940Orig1s000MedR.pdf"},{"key":"CIT0010","unstructured":"European Public Assessment Report PREVYMIS [Internet]. London (UK): European Medicines Agency; [cited 09\/11\/2018]. Available from: http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=pages\/medicines\/human\/medicines\/004536\/human_med_002200.jsp&mid=WC0b01ac058001d124"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.4084\/mjhid.2016.031"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2008.162"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1080\/13543784.2017.1274733"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199448030-00009"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(11)70024-X"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2012.04231.x"},{"key":"CIT0017","doi-asserted-by":"crossref","unstructured":"Papanicolaou G, Silveira FP, Langston A, et al. Maribavir for treatment of cytomegalovirus (CMV) infections resistant or refractory to ganciclovir or foscarnet in hematopoietic stem cell transplant (SCT) or solid organ transplant (SOT) recipients: a randomized, dose-ranging, double-blind, phase 2 study. IDWeek. Advacing science, improving care.; New Orl\u00e9ans, LA2016 October 26\u201330.","DOI":"10.1093\/ofid\/ofw194.13"},{"key":"CIT0018","doi-asserted-by":"crossref","unstructured":"Maertens J, Cordonnier C, Jaksch P, et al. Maribavir versus valganciclovir for pre-emptive treatment of cytomegalovirus viraemia: a randomized, dose-ranging, phase 2 study among haematopoietic stem cell transplant and solid organ transplant recipients. 43rd Annual Meeting of the European Society for Blood and Marrow Transplantation; Marseille, France2017 March 16\u201319.","DOI":"10.1016\/j.bbmt.2016.12.372"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1303688"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2016.01.009"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1097\/MPH.0000000000001227"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.3109\/14653249.2012.662769"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciq042"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.b.21367"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1097\/QCO.0000000000000375"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2017.16"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2007.02.004"},{"key":"CIT0028","unstructured":"Letermovir tablets and injection [Internet] Ltai. Dallas, Texas, USA: Drug Information; [cited 2018 july 06]. Available from: http:\/\/www.druginformation.com\/RxDrugs\/L\/LetermovirTabletsandInjection.html"},{"key":"CIT0029","unstructured":"AiCuris receives Orphan Drug Designation for Letermovir (AIC246) from FDA Wuppertal (Germany): AiCuris GmbH & Co. KG; 2012. Available from: http:\/\/www.aicuris.com\/75n10AiCuris-receives-Orphan-Drug-Designation-for-Letermovir-AIC246-from-FDA.htm"},{"key":"CIT0030","unstructured":"Approval letter PREVYMIS [Internet]. Silver Spring (USA): FDA; [updated 2017, cited 09\/11\/2018]"},{"key":"CIT0031","doi-asserted-by":"publisher","DOI":"10.1111\/cts.12483"},{"key":"CIT0032","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1706640"},{"key":"CIT0033","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.344"},{"key":"CIT0034","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01955-12"},{"key":"CIT0035","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01596-09"},{"key":"CIT0036","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.05265-11"},{"key":"CIT0037","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.05908-11"},{"key":"CIT0038","doi-asserted-by":"publisher","DOI":"10.1093\/femsre\/fuy004"},{"key":"CIT0039","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13376"},{"key":"CIT0040","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.116.071050"},{"key":"CIT0041","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.108.020503"},{"key":"CIT0042","doi-asserted-by":"publisher","DOI":"10.1021\/jm300212s"},{"key":"CIT0043","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-008-0553-z"},{"key":"CIT0044","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13292"},{"key":"CIT0045","doi-asserted-by":"publisher","DOI":"10.18433\/J3M89Q"},{"key":"CIT0046","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.09981110"},{"key":"CIT0047","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2011.03530.x"},{"key":"CIT0048","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2012.221"},{"key":"CIT0049","unstructured":"Package Insert PREVYMIS [Internet]. Silver Spring (USA). FDA; [updated 2017, cited 09\/11\/2018]."},{"key":"CIT0050","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.1094"},{"key":"CIT0051","doi-asserted-by":"crossref","unstructured":"Adedoyin A, Fox-Bosetti S, Fancourt C et al. Lack of pharmacokinetic interaction between single oral dosses of letermovir (MK8228) and fluconazole in healthy subjects. Poster presented at: North American ISSX meeting; 2018 July 15\u201319; Montr\u00e9al, Canada.","DOI":"10.1016\/j.dmpk.2018.09.144"},{"key":"CIT0052","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1309533"},{"key":"CIT0053","doi-asserted-by":"publisher","DOI":"10.1111\/tri.12225"},{"key":"CIT0054","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01794-13"},{"key":"CIT0055","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2015.01.006"},{"key":"CIT0056","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2014.08.014"},{"key":"CIT0057","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiv352"},{"issue":"5","key":"CIT0058","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1177\/135965350801300504","volume":"13","author":"Champier G","year":"2008","journal-title":"Antivir Ther"},{"key":"CIT0059","volume-title":"Abstract 1994. 50th Intersci. Conf. Antimicrob. Agents Chemother. (ICAAC)","author":"Kropeit D"},{"key":"CIT0060","doi-asserted-by":"publisher","DOI":"10.1002\/bdd.1992"},{"key":"CIT0061","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.104.003244"},{"key":"CIT0062","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.104.002477"}],"container-title":["Expert Opinion on Drug Metabolism & Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17425255.2018.1550485","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T23:17:25Z","timestamp":1662506245000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17425255.2018.1550485"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,2]]},"references-count":62,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12,2]]}},"alternative-id":["10.1080\/17425255.2018.1550485"],"URL":"https:\/\/doi.org\/10.1080\/17425255.2018.1550485","relation":{},"ISSN":["1742-5255","1744-7607"],"issn-type":[{"value":"1742-5255","type":"print"},{"value":"1744-7607","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,2]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iemt20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iemt20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2018-09-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-11-16","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-12-04","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}